Search
for
Sort by
Research 601–630 of 856
- Complications of liver transplantation: A perioperative perspective
- Teriflunomide in multiple sclerosis: an update
- Compliance With Contraceptives and Other Treatments
- Cutaneous Blood Flow.
- Drug eruptions in dermatology
- Viable terminal scalp hair follicles constitute a necessary and sufficient biological end‐organ that conditions clinical efficacy of finasteride in males with male pattern hair loss without implying reversal of miniaturized follicles
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
- Progress of Phage Therapy for Acne Vulgaris
- Amitriptyline-induced Telogen Effluvium in a Patient with Cervical Disc Prolapse: A Case Report
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia
- Dermatologie care behind bars
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Hair growth promotion by Necrostatin-1s
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- Growth factor mimetics for skin regeneration: In vitro profiling of primary human fibroblasts and keratinocytes
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- Scalp microbiome in male androgenetic alopecia: 16S rRNA sequencing-based clinical characterization, mouse model validation, and effects on hair follicle cells
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment